An open label study of the contraceptive efficacy of norethindrone [norethisterone] and ethinyl estradiol
Latest Information Update: 10 Nov 2021
Price :
$35 *
At a glance
- Drugs Ethinylestradiol/norethisterone (Primary)
- Indications Pregnancy
- Focus Therapeutic Use
- Sponsors Warner Chilcott
- 12 May 2009 Actual patient number (1702) added as reported by ClinicalTrials.gov.
- 12 May 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 27 Jan 2009 Planned end date changed from 1 Aug 2009 to 1 Feb 2009 as reported by ClinicalTrials.gov.